is .25 semaglutide effective Microdosing GLP-1 and GLP-2 medications like and tirzepatide becoming one of the most and sustainable approaches for patients who want metabolic support without jumping to 🥼🧪Slide Deck: Efficacy and safety

The Role of Comprehensive Labs Before starting any of these medications, we run comprehensive lab work including fasting insulin and HOMA-IR, HbA1c, complete metabolic panel, liver function, lipids, and thyroid

Because tirzepatide can be more potent for appetite suppression and weight loss, dose selection and escalation are especially important

Some patients experience fatigue without sleepiness, while others report that daytime drowsiness makes concentration difficult

Additional SURMOUNT Trials Cardiovascular Outcomes Trials SURPASS-CVOT (NCT04255433) Study Title: "Cardiovascular Outcomes Following Tirzepatide Treatment in Participants With Type 2 Diabetes and Increased Cardiovascular Risk" Status: Ongoing Phase: Phase 3 Enrollment: ~12,500 participants Study Period: 2020-2025 (estimated) Design: Randomized, double-blind, placebo-controlled event-driven trial Duration: Event-driven (minimum 3 years) Intervention: Tirzepatide up to 15 mg vs